Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Eurazeo is a Paris-based private equity and alternative asset manager with approximately €35 billion in AUM across private equity, private debt, real estate, and infrastructure strategies. The firm operates a diversified portfolio spanning European mid-market buyouts, growth capital, and specialized credit investments, with notable exposure to consumer, healthcare, and technology sectors. The stock trades at a significant discount to book value (0.5x P/B) reflecting investor concerns about portfolio valuations and negative operating cash flow.
Eurazeo generates predictable management fee revenue from long-duration fund commitments (10-12 year fund lives) while capturing asymmetric upside through carried interest on successful exits. The firm's competitive advantage lies in its European mid-market focus where competition is less intense than mega-buyouts, proprietary deal sourcing through sector-focused teams, and operational value creation capabilities. Unlike pure-play GPs, Eurazeo maintains significant balance sheet capital deployed alongside LPs, aligning interests but creating mark-to-market volatility. The negative operating margin (-91.8%) reflects accounting treatment of unrealized investment losses and performance fee reversals, not underlying fee-earning capacity.
Fundraising success and AUM growth trajectory - ability to raise successor funds at target sizes directly impacts forward fee revenue
Portfolio company exit activity and realized multiples - large exits (especially at 2.5x+ MOICs) drive carried interest crystallization and NAV appreciation
Mark-to-market valuation changes in private equity holdings - quarterly NAV adjustments reflect public market comparables and private transaction multiples
European M&A market conditions - deal flow, entry multiples, and financing availability determine deployment pace and return prospects
Currency movements (EUR/USD) - significant international LP base means dollar strength can impact fundraising competitiveness
Secular pressure on private equity fee structures as institutional investors negotiate lower management fees (1.25% vs historical 2.0%) and increased co-investment rights that reduce carried interest economics
Regulatory scrutiny intensifying across Europe regarding fee transparency, conflicts of interest, and portfolio company labor practices - potential for increased compliance costs and operational restrictions
Denominator effect risk where declining public equity valuations mechanically increase LP private equity allocations above target ranges, forcing reduced commitments to new funds
Intensifying competition from mega-funds (Blackstone, KKR, Carlyle) moving down-market into European mid-cap deals with larger equity checks and operational resources
Proliferation of sector-specialist funds and independent sponsors targeting the same European mid-market opportunity set with more focused value propositions
Direct lending and private credit strategies face competition from business development companies (BDCs) and credit-focused asset managers offering similar yields with daily liquidity
Extremely low current ratio (0.28x) indicates potential liquidity constraints and dependence on portfolio monetizations or credit facilities to fund operations and co-investment commitments
Negative operating cash flow (-$0.0B TTM) suggests the firm is consuming cash, likely due to timing mismatches between management fee collection and operating expenses or investment-related outflows
Concentration risk in balance sheet co-investments - significant unrealized losses could impair book value and trigger LP concerns about GP financial stability
high - Private equity returns are highly correlated with GDP growth, corporate earnings expansion, and exit market conditions. Portfolio company EBITDA growth drives value creation, while recession risk compresses exit multiples and delays monetization events. The firm's consumer and discretionary sector exposure amplifies cyclical sensitivity, though healthcare and infrastructure holdings provide some defensive balance.
Rising rates negatively impact Eurazeo through multiple channels: (1) higher financing costs reduce LBO returns and portfolio company debt service capacity, (2) increased discount rates compress private equity valuations and NAV, (3) elevated rates make alternative assets less attractive versus fixed income for LP allocations, and (4) refinancing risk emerges for portfolio companies with near-term debt maturities. The current 0.25x debt/equity suggests limited direct balance sheet exposure, but portfolio companies typically carry 4-6x leverage.
Significant exposure to credit market conditions. Private equity exits depend on robust leveraged finance markets for sponsor-to-sponsor transactions and dividend recapitalizations. Credit spread widening (high yield OAS expansion) reduces exit valuations and delays monetization timing. The firm's private debt strategies are directly exposed to corporate credit quality and default rates, with CLO and direct lending portfolios sensitive to refinancing risk and covenant compliance.
value - The 0.5x price/book ratio and 30%+ discount to NAV attracts deep value investors betting on portfolio realization and multiple re-rating. However, negative cash flow and operating margins deter growth-oriented investors. The stock appeals to contrarian investors with 3-5 year horizons willing to look through near-term mark-to-market volatility for eventual carried interest crystallization. Limited dividend yield makes this unsuitable for income-focused strategies.
high - Private equity stocks exhibit elevated volatility due to quarterly NAV mark-to-market adjustments, lumpy performance fee recognition, and sensitivity to broader equity market sentiment. European domicile adds currency volatility for USD-based investors. The stock's 30.5% decline over the past year and negative recent returns indicate above-market volatility, likely beta of 1.3-1.5x relative to European financials indices.
